Purchase Order 75F40121P00455
Award Date 9/2/21
Potential Completion Date 5/28/24
Potential Value $127K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $462,106.00 firm fixed-price purchase order to Rigaku Americas Corporation, a manufacturer of analytical X-ray instrumentation, for the provision of X-ray diffraction (XRD) systems. This contract was awarded under a competitive solicitation without a set-aside for small businesses and is intended to support the FDA's Center for Drug Evaluation and Research in testing and research to characterize opioid drug...
- The Food and Drug Administration (FDA) awarded a $96,929.40 firm-fixed-price purchase order to Agilent Technologies Inc. to provide three dissolution apparatus systems with sampling units, temperature probes, vessels, and other accessories. The FDA's Division of Product Quality Research has a requirement for this specialized laboratory equipment. The contract has an ultimate completion date of May 14, 2022 and was awarded on April 13, 2021. This purchase order is not associated with a...
- The U.S. Food and Drug Administration (FDA) awarded a $1,806,202.00 firm fixed price purchase order to Tescan USA Inc., a foreign-owned, for-profit organization, for the purchase, installation, training, and three-year extended service agreements for a TESCAN CLARA multi-vacuum field emission scanning electron microscope (SEM) with a gas monitor chamber and ion milling system. This advanced analytical instrument will be used by the FDA's Center for Drug Evaluation and Research, Office of...
- This $822,112.13 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Agilent Technologies Inc. (Agilent) on April 19, 2016 under the General Services Administration (GSA) Schedule 66 for Scientific Equipment and Services. The contract is for the delivery of a high resolution ion mobility quadrupole time-of-flight (QTOF) system to support research at the FDA. Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing...
- The Department of Health and Human Services Food and Drug Administration awarded a $323,129.68 firm fixed price purchase order to Agilent Technologies Inc. for a laser direct infrared imaging system to support compositional analysis of pharmaceutical products. The solicitation sought a system with capabilities including spectral matching, co-aligned visible and infrared images, and sample sizes up to 75mm to assist FDA in its regulatory responsibilities. Agilent Technologies will deliver the...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Wyatt Technology Corporation, a small business manufacturer of specialized analytical instrumentation and software. The $90,964.58 contract is for the provision of lab equipment, specifically multi-angle light scattering (MALS) detectors, field flow fractionation systems, dynamic light scattering instruments, and related software platforms. These highly precise scientific...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract valued at $327,080 to Molecular Vista, Inc. to procure an atomic force microscope coupled with photothermal infrared imaging capabilities. This acquisition, made under the FDA's Office of Acquisition and Grants Services, responds to a request for quotations seeking a system to physically and chemically characterize nanomaterials in drug products at the nanoscale level. As a total small business...
- The U.S. Food & Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) awarded a sole source delivery order to Agilent Technologies Inc. Customer Service And Sales Division for the purchase of an Agilent 6475 triple quadrupole mass spectrometer for the Office of Analytics and Outreach (OARSA) at a ceiling value of $249,782.34. This order is placed under the Multiple Award Schedule (MAS) master contract. The work will be performed in Marshallton, Delaware and is expected...
- The Food and Drug Administration awarded a delivery order valued at $34,898.96 to Agilent Technologies Inc. on April 10, 2026, for an Agilent 1290 Infinity III Evaporative Light Scattering Detector with an ultimate completion date of July 9, 2026. This firm fixed-price delivery order was issued under the Multiple Award Schedule (MAS) contract vehicle and does not utilize a set-aside designation. The equipment will be delivered to Marshallton, Delaware. Agilent Technologies Inc., headquartered in...
- The Food and Drug Administration awarded a $191,011.32 delivery order to Agilent Technologies Inc.'s Customer Service and Sales division on March 16, 2020, for corrective, remedial repair, and preventive maintenance services on Agilent 6550 Time-of-Flight Quadrupole Time-of-Flight (QTOF) mass spectrometry and Agilent 1290 Ultra-Performance Liquid Chromatography (UPLC) systems. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by...
The U.S. Food & Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) has awarded a firm-fixed-price purchase order to Quantum Detectors Limited, a foreign-owned for-profit organization, to upgrade a detector system in a small-angle X-ray scattering (SAXS) measurement setup. The order, valued at $126,950.00, has a completion date of May 28, 2024. This award is related to a previous sole-source acquisition from Agilent Technologies Inc. for a Real Time Cell Analysis System (xCELLigence) under Request for Quote RFQ-FDA-2021-1238228. The contract was not set aside for any socioeconomic program.
Generated 3/23/24, 6:22 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/18/22 | |
| Not listed | Not listed | $127.0k | 9/2/21 |